You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Blincyto

Showing 1 - 25 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-cell Acute Lymphoblastic Leukemia Trial in Tampa, Durham, Winston-Salem (Blinatumomab)

Withdrawn
  • B-cell Acute Lymphoblastic Leukemia
  • Tampa, Florida
  • +2 more
Feb 14, 2022

Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)

Not yet recruiting
  • Solid Tumor, Adult
  • CF33-CD19 IT
  • +2 more
  • (no location specified)
Sep 26, 2023

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting
  • B Precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 25, 2023

Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 30, 2022

Acute Lymphoid Leukemia Trial in Seoul (Blincyto)

Not yet recruiting
  • Acute Lymphoid Leukemia
  • Blincyto
  • Seoul, Gangnam-gu, Korea, Republic of
  • +4 more
Apr 12, 2023

Mixed Phenotype Acute Leukemia (MPAL), Measurable Residual Disease (MRD) Trial in Baltimore (BLINCYTO (Blinatumomab))

Recruiting
  • Mixed Phenotype Acute Leukemia (MPAL)
  • Measurable Residual Disease (MRD)
  • BLINCYTO (Blinatumomab)
  • Baltimore, Maryland
    Greenebaum Cancer Center at University of Maryland Medical Cente
Apr 18, 2022

Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Saint Louis, Missouri
    Washington University School of Medicine
May 4, 2022

Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)

Not yet recruiting
  • Refractory Acute Lymphoblastic Leukemia
  • Relapsed Acute Lymphoblastic Leukemia
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 23, 2022

B-Cell Acute Lymphoblastic Leukemia, Adult Trial in La Jolla, Orange, San Francisco (blinatumomab, pembrolizumab)

Terminated
  • B-Cell Acute Lymphoblastic Leukemia, Adult
  • La Jolla, California
  • +2 more
Apr 26, 2022

Lymphoblastic Leukemia, Acute, Adult, Ph Negative ALL, Newly Diagnosed Trial in Czechia (Blinatumomab)

Active, not recruiting
  • Lymphoblastic Leukemia, Acute, Adult
  • +2 more
  • Brno, Czechia
  • +4 more
Aug 3, 2022

ALL, Recurrent, Adult Trial in Frankfurt (Main), Kiel (Blinatumomab, Venetoclax)

Recruiting
  • ALL, Recurrent, Adult
  • Frankfurt (Main), Hessen, Germany
  • +1 more
Jan 6, 2022

ALL, Childhood, Minimal Residual Disease Trial in Worldwide (Blinatumomab)

Recruiting
  • ALL, Childhood
  • Minimal Residual Disease
  • Vienna, Austria(AUT), Austria
  • +14 more
Mar 4, 2021

B-Precursor ALL Trial in Germany (Blinatumomab)

Recruiting
  • B-Precursor ALL
  • Frankfurt (Main), Hessen, Germany
  • +20 more
Aug 16, 2022

B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, B-Cell ALL, Childhood Trial in Milwaukee

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Sep 12, 2021

ALL, Recurrent, Adult Trial in Germany (Blinatumomab)

Active, not recruiting
  • ALL, Recurrent, Adult
  • Frankfurt (Main), Hessen, Germany
  • +21 more
Mar 16, 2022

Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia Trial in Japan (Blinatumomab)

Completed
Has Results
  • Relapsed Refractory B Precursor Acute Lymphoblastic Leukemia
  • Nagoya-shi, Aichi, Japan
  • +15 more
Dec 8, 2022

ALL, Adult Trial in Belgium, Netherlands (Blinatumomab)

Active, not recruiting
  • ALL, Adult
  • Antwerpen, Belgium
  • +17 more
Dec 29, 2021

Relapsed/Refractory Philadelphia Positive B-precursor ALL Trial in Worldwide (Blinatumomab)

Completed
Has Results
  • Relapsed/Refractory Philadelphia Positive B-precursor ALL
  • Duarte, California
  • +21 more
Sep 8, 2022

Non-Hodgkin Lymphoma Trial in Boston (Blinatumomab)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Boston, Massachusetts
    Massachusetts general Hospital
Jan 31, 2021

Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory B Acute Lymphoblastic Leukemia

Recruiting
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Blinatumomab
  • +2 more
  • New Haven, Connecticut
  • +6 more
Jul 9, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

Acute Lymphoblastic Leukemia, Adult Trial (Ponatinib, Blinatumomab, Imatinib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • (no location specified)
Dec 28, 2020

Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab, AMG 404, Dexamethasone Premedication)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • Duarte, California
  • +18 more
Jul 27, 2022

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022